rxstat › Shortages › Galantamine

Galantamine shortage status

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Galantamine has no current shortage reported in Canada. It has been in shortage before; the history is below.
Products affected
0 / 19
Reports on file
62

Reports by product

Resolved
MYLAN-GALANTAMINE ER
16MG · CAPSULE (EXTENDED RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02339447 · ended Jan 22, 2026 · Demand increase for the drug.
Resolved
GALANTAMINE ER
8MG · CAPSULE (EXTENDED RELEASE) · SANIS HEALTH INC
DIN 02443015 · ended Jun 13, 2025 · Disruption of the manufacture of the drug.
Resolved
MYLAN-GALANTAMINE ER
24MG · CAPSULE (EXTENDED RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02339455 · ended May 20, 2025 · Demand increase for the drug.
Resolved
AURO-GALANTAMINE ER
8MG · CAPSULE (EXTENDED RELEASE) · AURO PHARMA INC
DIN 02425157 · ended Dec 16, 2024 · Demand increase for the drug.
Resolved
AURO-GALANTAMINE ER
16MG · CAPSULE (EXTENDED RELEASE) · AURO PHARMA INC
DIN 02425165 · ended Jul 16, 2024 · Demand increase for the drug.
Resolved
AURO-GALANTAMINE ER
16MG · CAPSULE (EXTENDED RELEASE) · AURO PHARMA INC
DIN 02425165 · ended Jun 24, 2024 · Demand increase for the drug.
Resolved
AURO-GALANTAMINE ER
16MG · CAPSULE (EXTENDED RELEASE) · AURO PHARMA INC
DIN 02425165 · ended Apr 29, 2024 · Demand increase for the drug.
Resolved
GALANTAMINE ER
16MG · CAPSULE (EXTENDED RELEASE) · SANIS HEALTH INC
DIN 02443023 · ended Apr 3, 2024 · Disruption of the manufacture of the drug.
Resolved
GALANTAMINE ER
8MG · CAPSULE (EXTENDED RELEASE) · SANIS HEALTH INC
DIN 02443015 · ended Apr 3, 2024 · Disruption of the manufacture of the drug.
Resolved
MYLAN-GALANTAMINE ER
8MG · CAPSULE (EXTENDED RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02339439 · ended Mar 19, 2024 · Disruption of the manufacture of the drug.
Resolved
MYLAN-GALANTAMINE ER
16MG · CAPSULE (EXTENDED RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02339447 · ended Mar 19, 2024 · Disruption of the manufacture of the drug.
Resolved
GALANTAMINE ER
8MG · CAPSULE (EXTENDED RELEASE) · SANIS HEALTH INC
DIN 02443015 · ended Jan 18, 2024 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

There are no active shortage reports for Galantamine. Health Canada has 62 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Galantamine is classified under “ANTI-DEMENTIA DRUGS” (ATC N06DA).

Recent changes

Common questions

When will Galantamine be back in stock in Canada?

Galantamine has no active shortage; supply is normal per Health Canada reports.

Why is Galantamine in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (anti-dementia drugs)

Partial shortageDonepezil14 of 39 reported products affected · est. return Oct 10, 2026Partial shortageMemantine2 of 12 reported products affected · est. return Jul 11, 2026Partial shortageRivastigmine1 of 30 reported products affected · est. return Sep 15, 2025

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.